{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:45:21Z","timestamp":1782740721035,"version":"3.54.5"},"reference-count":167,"publisher":"Elsevier","isbn-type":[{"value":"9780443471001","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.acc.2026.03.005","type":"book-chapter","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:06:33Z","timestamp":1775559993000},"page":"1-46","source":"Crossref","is-referenced-by-count":0,"title":["Biomarkers in heart failure"],"prefix":"10.1016","author":[{"given":"Manuel","family":"Garofalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Panichella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Aimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.acc.2026.03.005_bib0001","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/eurheartj\/ehac248","article-title":"An update on global epidemiology in heart failure","volume":"43","author":"Becher","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/bs.acc.2026.03.005_bib0002","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","article-title":"Global epidemiology of heart failure","volume":"21","author":"Khan","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0003","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jacc.2022.11.023","article-title":"Worsening heart failure: nomenclature, epidemiology, and future directions: JACC review topic of the week","volume":"81","author":"Greene","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0004","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.15420\/cfr.2023.05","article-title":"Global public health burden of heart failure: an updated review","volume":"9","author":"Shahim","year":"2023","journal-title":"Card Fail. Rev."},{"key":"10.1016\/bs.acc.2026.03.005_bib0005","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2026.03.005_bib0006","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/bs.acc.2026.03.005_bib0007","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/bs.acc.2022.09.005","article-title":"Advances in congestive heart failure biomarkers","volume":"112","author":"Mohan","year":"2023","journal-title":"Advances in Clinical Chemistry"},{"key":"10.1016\/bs.acc.2026.03.005_bib0008","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10741-021-10105-w","article-title":"Biomarkers for the diagnosis and management of heart failure","volume":"27","author":"Castiglione","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/bs.acc.2026.03.005_bib0009","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2310\/JIM.0b013e3182946b69","article-title":"Natriuretic peptides as biomarkers in heart failure","volume":"61","author":"Januzzi","year":"2013","journal-title":"J. Investig. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ejhf.273","article-title":"State of the art: newer biomarkers in heart failure","volume":"17","author":"de Boer","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0011","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ejhf.1654","article-title":"Cardiovascular and non-cardiovascular death distinction: the utility of troponin beyond N-terminal pro-B-type natriuretic peptide. Findings from the BIOSTAT-CHF study","volume":"22","author":"Ferreira","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0012","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchf.2014.10.007","volume":"3","author":"Desta","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-72137-0","article-title":"High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failure","volume":"14","author":"Santas","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2026.03.005_bib0014","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12967-022-03466-9","article-title":"Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study","volume":"20","author":"Van Tassell","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9247574","article-title":"The many roles of galectin-3, a multifaceted molecule, in Innate immune responses against pathogens","volume":"2017","author":"D\u00edaz-Alvarez","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/bs.acc.2026.03.005_bib0016","first-page":"906","article-title":"Understanding Galectin-3\u2019s role in diastolic dysfunction: a contemporary perspective","volume":"14","author":"Hao","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/bs.acc.2026.03.005_bib0017","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98227-x","article-title":"Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus","volume":"11","author":"Schmitt","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2026.03.005_bib0019","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/CIRCHEARTFAILURE.111.963637","article-title":"Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study","volume":"5","author":"Felker","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCHEARTFAILURE.112.000129","article-title":"Prognostic value of changes in galectin-3 levels over time in patients with heart failure","volume":"6","author":"van der Velde","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0021","first-page":"468","article-title":"Soluble ST2 in heart failure: a clinical role beyond B-type natriuretic peptide","volume":"10","author":"Riccardi","year":"2023","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/bs.acc.2026.03.005_bib0022","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2007.05.014","article-title":"Measurement of the interleukin Family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study","volume":"50","author":"Januzzi","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0023","doi-asserted-by":"crossref","first-page":"76B","DOI":"10.1016\/j.amjcard.2015.01.045","article-title":"Multimarker testing with ST2 in chronic heart failure","volume":"115","author":"Bayes-Genis","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0024","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jchf.2016.12.016","article-title":"Meta-analysis of soluble suppression of tumorigenicity-2 and prognosis in acute heart failure","volume":"5","author":"Aimo","year":"2017","journal-title":"JACC Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0025","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ejhf.3036","article-title":"Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: a clinical consensus statement from the Heart Failure Association of the ESC","volume":"25","author":"Bayes-Genis","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0026","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2018.04.045","article-title":"Natriuretic peptides in heart failure: current achievements and future perspectives","volume":"281","author":"Volpe","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0027","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.3390\/ijms20163991","article-title":"Natriuretic peptides in the cardiovascular system: multifaceted roles in physiology, pathology and therapeutics","volume":"20","author":"Rubattu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.acc.2026.03.005_bib0028","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity","volume":"53","author":"Harper","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/bs.acc.2026.03.005_bib0029","doi-asserted-by":"crossref","first-page":"14","DOI":"10.15420\/cfr.2016:4:2","article-title":"Current understanding of the compensatory actions of cardiac natriuretic peptides in cardiac failure: a clinical perspective","volume":"2","author":"Lee","year":"2016","journal-title":"Card Fail. Rev."},{"key":"10.1016\/bs.acc.2026.03.005_bib0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1937-6448(08)00803-4","article-title":"Natriuretic peptides in vascular physiology and pathology","volume":"268","author":"Woodard","year":"2008","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0031","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/mol.104.002436","article-title":"Down-regulation does not mediate natriuretic peptide-dependent desensitization of natriuretic peptide receptor (NPR)-A or NPR-B: guanylyl cyclase-linked natriuretic peptide receptors do not internalize","volume":"67","author":"Fan","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0032","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3390\/ijms23042145","article-title":"Phosphodiesterases and compartmentation of cAMP and cGMP signaling in regulation of cardiac contractility in normal and failing hearts","volume":"23","author":"Calamera","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.acc.2026.03.005_bib0033","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.CIR.0000025242.79963.4C","article-title":"B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure","volume":"106","author":"McCullough","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2026.03.005_bib0034","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0035","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cardfail.2023.02.009","article-title":"Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society","volume":"29","author":"Tsutsui","year":"2023","journal-title":"J. Card. Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0036","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jacc.2018.01.021","article-title":"N-terminal Pro-B-type natriuretic peptide in the emergency department: the ICON-RELOADED study","volume":"71","author":"Januzzi","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0037","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/eurheartj\/ehi631","article-title":"NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP study","volume":"27","author":"Januzzi","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/bs.acc.2026.03.005_bib0038","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.124.072156","article-title":"Evidence-based application of natriuretic peptides in the evaluation of chronic heart failure with preserved ejection fraction in the ambulatory outpatient setting","volume":"151","author":"Reddy","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2026.03.005_bib0039","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijcard.2006.03.084","article-title":"Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure","volume":"117","author":"Corell","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jchf.2020.03.003","article-title":"The challenges of NT-proBNP testing in HFpEF: shooting arrows in the wind","volume":"8","author":"Januzzi","year":"2020","journal-title":"JACC Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0041","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12933-025-02612-z","article-title":"Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity","volume":"24","author":"van Dalen","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0042","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejhf.2894","volume":"25","author":"Anker","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0043","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA\u2013PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/bs.acc.2026.03.005_bib0044","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/hrt.2003.018325","article-title":"Natriuretic peptides as a prognostic marker and therapeutic target in heart failure","volume":"92","author":"Wright","year":"2006","journal-title":"Heart"},{"key":"10.1016\/bs.acc.2026.03.005_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1373\/clinchem.2003.024760","article-title":"Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review","volume":"50","author":"Clerico","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2026.03.005_bib0046","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jchf.2023.11.007","article-title":"Prognostic impact of repeated NT-proBNP measurements in patients with heart failure with reduced ejection fraction","volume":"12","author":"Fuery","year":"2024","journal-title":"JACC Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0047","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCHEARTFAILURE.111.962290","article-title":"Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes","volume":"4","author":"Kociol","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0048","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.1016\/j.healun.2023.02.856","article-title":"(843) Change in NT-ProBNP to predict development of right, left, and biventricular heart failure in heartmate 3 LVAD patients","volume":"42","author":"Gamero","year":"2023","journal-title":"J. Heart Lung Transpl."},{"key":"10.1016\/bs.acc.2026.03.005_bib0049","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.cardfail.2005.04.007","article-title":"Improvement of serum NT-ProBNP predicts Improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure","volume":"11","author":"Yu","year":"2005","journal-title":"J. Card. Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0050","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2006.10.081","article-title":"Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP multicenter study","volume":"49","author":"Jourdain","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0051","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.cardfail.2012.05.005","article-title":"Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study","volume":"18","author":"Gaggin","year":"2012","journal-title":"J. Card. Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0052","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.2017.10565","article-title":"Effect of natriuretic peptide\u2013guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial","volume":"318","author":"Felker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/bs.acc.2026.03.005_bib0053","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jchf.2018.02.007","article-title":"Natriuretic peptides as biomarkers of treatment response in clinical trials of heart failure","volume":"6","author":"Vaduganathan","year":"2018","journal-title":"JACC Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0054","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/cpt.2222","article-title":"NT-proBNP qualifies as a surrogate for clinical end points in heart failure","volume":"110","author":"Schmitt","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/bs.acc.2026.03.005_bib0055","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013Neprilysin inhibition versus Enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0056","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11897-020-00458-y","article-title":"Angiotensin receptor\u2013Neprilysin inhibitors and the natriuretic peptide axis","volume":"17","author":"Vasquez","year":"2020","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/bs.acc.2026.03.005_bib0057","first-page":"1034","article-title":"B-type natriuretic peptide (BNP) revisited-is BNP still a biomarker for heart failure in the angiotensin receptor\/neprilysin inhibitor era?","volume":"11","author":"Nishikimi","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/bs.acc.2026.03.005_bib0058","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin\u2013Neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0059","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal pro\u2013B-type natriuretic peptide following initiation of Sacubitril-Valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/bs.acc.2026.03.005_bib0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2018.04.045","article-title":"Natriuretic peptides in heart failure: current achievements and future perspectives","volume":"281","author":"Volpe","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0061","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acc.2026.03.005_bib0062","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003957","article-title":"Dipeptidyl peptidase-4 inhibitors and risk of heart failure in patients with type 2 diabetes mellitus: a population-based cohort study","volume":"10","author":"Kim","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0063","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1074\/jbc.M110.173252","article-title":"Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response","volume":"286","author":"Ralat","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2026.03.005_bib0064","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jchf.2021.05.022","article-title":"What is the effect of obesity on the natriuretic peptide pathway?","volume":"9","author":"Herrmann","year":"2021","journal-title":"JACC Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijcard.2014.08.007","article-title":"Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure","volume":"176","author":"Madamanchi","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0066","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.105.555573","article-title":"Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study","volume":"112","author":"Das","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2026.03.005_bib0067","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.trsl.2017.06.001","article-title":"Modulation of natriuretic peptide receptors in human adipose tissue: molecular mechanisms behind the \u201cnatriuretic handicap\u201d in morbidly obese patients","volume":"186","author":"Gentili","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/bs.acc.2026.03.005_bib0068","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/archinte.167.4.400","article-title":"Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea","volume":"167","author":"Bayes-Genis","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0069","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/ejhf.2618","article-title":"Clinical effect of obesity on N-terminal pro-B-type natriuretic peptide cut-off concentrations for the diagnosis of acute heart failure","volume":"24","author":"Kozhuharov","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2023.05.014","article-title":"Associations of N-terminal Pro-B-type natriuretic peptide, estimated glomerular filtration rate, and mortality in US adults","volume":"264","author":"Ozkan","year":"2023","journal-title":"Am. Heart J."},{"key":"10.1016\/bs.acc.2026.03.005_bib0071","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1751-7133.2010.00153.x","article-title":"Impact of kidney dysfunction on plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute heart failure","volume":"16","author":"Manzano-Fern\u00e1ndez","year":"2010","journal-title":"Congest. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0072","doi-asserted-by":"crossref","first-page":"sfae298","DOI":"10.1093\/ckj\/sfae298","article-title":"N-terminal pro-B-type natriuretic peptide, eGFR, and progression of kidney disease in chronic kidney disease patients without heart failure","volume":"17","author":"Lu","year":"2024","journal-title":"Clin. Kidney J."},{"key":"10.1016\/bs.acc.2026.03.005_bib0073","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nefro.2015.03.002","article-title":"Clinical value of natriuretic peptides in chronic kidney disease","volume":"35","author":"Santos-Ara\u00fajo","year":"2015","journal-title":"Nefrologia"},{"key":"10.1016\/bs.acc.2026.03.005_bib0074","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/ndt\/gfi187","article-title":"Diagnostic potential of circulating natriuretic peptides in chronic kidney disease","volume":"21","author":"Mark","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2026.03.005_bib0075","first-page":"313","article-title":"Consensus document and recommendations on the use of natriuretic peptides in clinical practice","volume":"216","author":"Pascual-Figal","year":"2016","journal-title":"Rev. Cl\u00edn. Esp. (English Edition)"},{"key":"10.1016\/bs.acc.2026.03.005_bib0076","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3889\/oamjms.2016.011","article-title":"Cardiac biomarkers and left ventricular hypertrophy in asymptomatic hemodialysis patients","volume":"4","author":"Koycheva","year":"2016","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"10.1016\/bs.acc.2026.03.005_bib0077","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2024.08.009","article-title":"Natriuretic peptides, kidney function, and clinical outcomes in heart failure with preserved ejection fraction","volume":"13","author":"Neuen","year":"2025","journal-title":"JACC Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0078","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-67529-1","article-title":"Plasma B-type natriuretic peptide is independently associated with cardiovascular events and mortality in patients with chronic kidney disease","volume":"14","author":"Hayashida","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2026.03.005_bib0079","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/jcp.2003.015420","article-title":"Cardiac troponins","volume":"57","author":"Sharma","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0080","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/cvr\/cvx183","article-title":"Cardiac troponins: from myocardial infarction to chronic disease","volume":"113","author":"Park","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/bs.acc.2026.03.005_bib0081","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11897-023-00588-z","article-title":"What is the clinical utility of cardiac troponins in heart failure? Are they modifiable beyond their prognostic value?","volume":"20","author":"Agdashian","year":"2023","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/bs.acc.2026.03.005_bib0082","first-page":"371","article-title":"Troponins in heart \u2014failurea perpetual challenge","volume":"14","author":"Gherasim","year":"2019","journal-title":"Maedica (Bucur)"},{"key":"10.1016\/bs.acc.2026.03.005_bib0083","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejim.2022.01.012","article-title":"High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis","volume":"98","author":"Aimo","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0084","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCHEARTFAILURE.113.000450","article-title":"Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial","volume":"7","author":"Gravning","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/CIRCULATIONAHA.111.044149","article-title":"Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials","volume":"125","author":"Masson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2026.03.005_bib0086","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/eurheartj\/ehs163","article-title":"High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate","volume":"33","author":"Scheven","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/bs.acc.2026.03.005_bib0087","first-page":"54","article-title":"The prognostic role of high-sensitivity cardiac troponin T over time in ischemic and non-ischemic heart failure","volume":"17","author":"Li","year":"2021","journal-title":"Postepy Kardiol. Interwencyjnej"},{"key":"10.1016\/bs.acc.2026.03.005_bib0088","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010364","article-title":"High-sensitivity troponin I in hospitalized and ambulatory patients with heart failure with preserved ejection fraction: insights from the heart failure clinical research network","volume":"7","author":"Fudim","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/bs.acc.2026.03.005_bib0089","doi-asserted-by":"crossref","first-page":"102","DOI":"10.15420\/cfr.2015.1.2.102","article-title":"Role of cardiac troponin levels in acute heart failure","volume":"1","author":"Wettersten","year":"2015","journal-title":"Card Fail. Rev."},{"key":"10.1016\/bs.acc.2026.03.005_bib0090","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa0706824","article-title":"Cardiac troponin and outcome in acute heart failure","volume":"358","author":"Peacock","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0091","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ejheart.2008.06.009","article-title":"Clinical significance of cardiac troponins I and T in acute heart failure","volume":"10","author":"Ilva","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0092","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1801291","article-title":"Effects of Serelaxin in patients with acute heart failure","volume":"381","author":"Metra","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0093","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jacc.2023.05.035","article-title":"C-reactive protein and risk of incident heart failure in patients with cardiovascular disease","volume":"82","author":"Burger","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0094","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/CIRCULATIONAHA.104.508465","article-title":"C-reactive protein in heart failure","volume":"112","author":"Anand","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2026.03.005_bib0095","first-page":"439","article-title":"High-sensitivity C-reactive protein: clinical importance","volume":"29","author":"Bassuk","year":"2004","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0096","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker Valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0097","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1388-9842(02)00021-1","article-title":"C-reactive protein as a predictor of improvement and readmission in heart failure","volume":"4","author":"Alonso-Mart\u00ednez","year":"2002","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0098","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1159\/000343302","article-title":"C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation","volume":"30","author":"Hsuchou","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/bs.acc.2026.03.005_bib0099","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1304735","article-title":"Unraveling the role of galectin-3 in cardiac pathology and physiology","volume":"14","author":"Seropian","year":"2023","journal-title":"Front Physiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jchf.2014.12.009","article-title":"Evolving role of Galectin-3 as a cardiac biomarker","volume":"3","author":"deFilippi","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0101","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ahj.2012.08.021","article-title":"The predictive value of galectin-3 for mortality and cardiovascular events in the controlled rosuvastatin multinational trial in heart failure (CORONA)","volume":"164","author":"Gullestad","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/bs.acc.2026.03.005_bib0102","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003700","article-title":"Prognostic value of serial galectin-3 measurements in patients with acute heart failure","volume":"6","author":"van Vark","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/bs.acc.2026.03.005_bib0103","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00475","article-title":"The ST2\/IL-33 axis in immune cells during inflammatory diseases","volume":"8","author":"Griesenauer","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0104","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2026.03.005_bib0105","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3390\/cells9071667","article-title":"Soluble St2 induces cardiac fibroblast activation and collagen synthesis via neuropilin-1","volume":"9","author":"Matilla","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.acc.2026.03.005_bib0106","first-page":"145","article-title":"Soluble ST2 testing: a promising biomarker in the management of heart failure","volume":"106","author":"Villacorta","year":"2016","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0107","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchf.2013.10.005","article-title":"Head-to-head comparison of serial soluble ST2, growth differentiation Factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure","volume":"2","author":"Gaggin","year":"2014","journal-title":"JACC Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0108","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/CIRCHEARTFAILURE.113.000457","article-title":"Soluble concentrations of the interleukin receptor family member ST2 and \u03b2-blocker therapy in chronic heart failure","volume":"6","author":"Gaggin","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0109","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63880-5","article-title":"Growth\/differentiation factor 15 (GDF15) expression in the heart after myocardial infarction and cardioprotective effect of pre-ischemic rGDF15 administration","volume":"14","author":"Dogon","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2026.03.005_bib0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.31083\/j.rcm2403081","article-title":"Role of the stress- and inflammation-induced cytokine GDF-15 in cardiovascular diseases: from basic research to clinical relevance","volume":"24","author":"Schwarz","year":"2023","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0111","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1089\/ars.2019.7971","article-title":"Myeloperoxidase as a multifaceted target for cardiovascular protection","volume":"32","author":"Ramachandra","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/bs.acc.2026.03.005_bib0112","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.ATV.0000163262.83456.6d","article-title":"Myeloperoxidase and cardiovascular disease","volume":"25","author":"Nicholls","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0113","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1515\/cclm-2014-0222","article-title":"Novel biomarkers in acute heart failure: MR-pro-adrenomedullin","volume":"52","author":"Peacock","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0114","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ejhf.331","article-title":"Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study","volume":"17","author":"Cotter","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0115","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1161\/CIRCULATIONAHA.110.979740","article-title":"Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults","volume":"123","author":"Daniels","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2026.03.005_bib0116","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jchf.2017.07.013","article-title":"Utility of growth differentiation Factor-15, A marker of oxidative stress and inflammation, in chronic heart failure: insights from the HF-ACTION study","volume":"5","author":"Sharma","year":"2017","journal-title":"JACC Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0117","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009526","article-title":"Multimarker analysis of serially measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, creatinine, and prognosis in acute heart failure","volume":"16","author":"G\u00fcrg\u00f6ze","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0118","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.amjcard.2006.04.018","article-title":"Plasma myeloperoxidase levels in patients with chronic heart failure","volume":"98","author":"Tang","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0119","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jacc.2007.02.053","article-title":"Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure","volume":"49","author":"Tang","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.31083\/j.rcm2402056","article-title":"Association of plasma myeloperoxidase with inflammation and diabetic status in HFpEF","volume":"24","author":"Lejeune","year":"2023","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0121","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cca.2019.02.022","article-title":"Myeloperoxidase\u2014a bridge linking inflammation and oxidative stress with cardiovascular disease","volume":"493","author":"Ndrepepa","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/bs.acc.2026.03.005_bib0122","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.atherosclerosis.2013.03.006","article-title":"Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease","volume":"228","author":"Neumann","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.acc.2026.03.005_bib0123","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3390\/medicina58101477","article-title":"Relation between mid-regional pro-adrenomedullin in patients with chronic heart failure and the dose of diuretics in 2-year follow-up-data from FAR NHL Registry","volume":"58","author":"\u0160pinarov\u00e1","year":"2022","journal-title":"Medicina (Kaunas)."},{"key":"10.1016\/bs.acc.2026.03.005_bib0124","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3390\/jpm13071155","article-title":"Mid-regional pro-adrenomedullin and N-terminal pro-B-type natriuretic peptide measurement: a multimarker approach to diagnosis and prognosis in acute heart failure","volume":"13","author":"Spoto","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0125","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jacc.2011.06.006","article-title":"Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial","volume":"58","author":"Maisel","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0126","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11897-012-0096-6","article-title":"Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?","volume":"9","author":"Potocki","year":"2012","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/bs.acc.2026.03.005_bib0127","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bbamcr.2010.06.013","article-title":"MicroRNAs: synthesis, mechanism, function, and recent clinical trials","volume":"1803","author":"Wahid","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.acc.2026.03.005_bib0128","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/cells8070737","article-title":"MicroRNAs in cardiac diseases","volume":"8","author":"Colpaert","year":"2019","journal-title":"Cells"},{"key":"10.1016\/bs.acc.2026.03.005_bib0129","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrd3864","article-title":"MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles","volume":"11","author":"van Rooij","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/bs.acc.2026.03.005_bib0130","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cardfail.2023.04.011","article-title":"Parity and future myocardial dysfunction: getting to the heart of the matter","volume":"29","author":"Mogos","year":"2023","journal-title":"J. Card. Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0131","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","article-title":"MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances","volume":"43","author":"Metcalf","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/bs.acc.2026.03.005_bib0132","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ejhf.495","article-title":"MicroRNAs in heart failure: from biomarker to target for therapy","volume":"18","author":"Vegter","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0133","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12967-022-03465-w","article-title":"Diagnostic potential of a circulating miRNA model associated with therapeutic effect in heart failure","volume":"20","author":"Qian","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0134","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.00161","article-title":"The role of microRNAs in heart failure: a systematic review","volume":"7","author":"Peterlin","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0135","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1007\/s00330-020-07454-9","article-title":"Deep learning algorithm to improve hypertrophic cardiomyopathy mutation prediction using cardiac cine images","volume":"31","author":"Zhou","year":"2021","journal-title":"Eur. Radiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0136","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2018.11.060","article-title":"Combining circulating MicroRNA and NT-proBNP to detect and categorize heart failure subtypes","volume":"73","author":"Wong","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0137","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","article-title":"MicroRNAs in the human heart","volume":"116","author":"Thum","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2026.03.005_bib0138","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.856358","article-title":"The microRNA expression profiling in heart failure: a systematic review and meta-analysis","volume":"9","author":"Shen","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0139","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.3390\/jcm13247560","article-title":"MicroRNA and heart failure: a novel promising diagnostic and therapeutic tool","volume":"13","author":"D\u2019Amato","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0140","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10741-020-10071-9","article-title":"A meta-analysis of microRNA expression profiling studies in heart failure","volume":"26","author":"Gholaminejad","year":"2021","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/bs.acc.2026.03.005_bib0141","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ehf2.14153","article-title":"MicroRNAs: diagnostic, prognostic and therapeutic role in heart failure\u2014a review","volume":"10","author":"Gargiulo","year":"2023","journal-title":"ESC Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0142","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10557-023-07492-7","article-title":"Advances in MicroRNA therapy for heart failure: clinical trials, preclinical studies, and controversies","volume":"39","author":"Huang","year":"2025","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/bs.acc.2026.03.005_bib0143","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.950284","article-title":"Long non-coding RNAs in the pathogenesis of heart failure: a literature review","volume":"9","author":"Fan","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0144","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41569-023-00952-5","article-title":"Long non-coding RNAs in cardiac hypertrophy and heart failure: functions, mechanisms and clinical prospects","volume":"21","author":"Mably","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/bs.acc.2026.03.005_bib0145","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s12265-013-9488-6","article-title":"Long noncoding RNA: a new player of heart failure?","volume":"6","author":"Papait","year":"2013","journal-title":"J. Cardiovasc. Trans. Res."},{"key":"10.1016\/bs.acc.2026.03.005_bib0146","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1300375","article-title":"Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction","volume":"10","author":"Jalink","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0147","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/ncrna10010003","article-title":"Long non-coding RNAs (lncRNAs) in heart failure: a comprehensive review","volume":"10","author":"Jha","year":"2024","journal-title":"Non-Coding RNA"},{"key":"10.1016\/bs.acc.2026.03.005_bib0148","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1177\/15353702211036055","article-title":"Circulating LIPCAR is a potential biomarker of heart failure in patients post-acute myocardial infarction","volume":"246","author":"Yan","year":"2021","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/bs.acc.2026.03.005_bib0149","first-page":"172","article-title":"LncRNA H19: a novel biomarker in cardiovascular disease","volume":"40","author":"Li","year":"2024","journal-title":"Acta Cardiol. Sin."},{"key":"10.1016\/bs.acc.2026.03.005_bib0150","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.hlc.2021.10.022","article-title":"The functions of long non-coding RNA (lncRNA) H19 in the heart","volume":"31","author":"Wang","year":"2022","journal-title":"Heart Lung Circ."},{"key":"10.1016\/bs.acc.2026.03.005_bib0151","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00018-021-04046-8","article-title":"MIAT, a potent CVD-promoting lncRNA","volume":"79","author":"Yang","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/bs.acc.2026.03.005_bib0152","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.601364","article-title":"Biomarkers for heart failure prognosis: proteins, genetic scores and non-coding RNAs","volume":"7","author":"Shrivastava","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0153","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/jcmm.13101","article-title":"Circulating long non-coding RNAs NRON and MHRT as novel predictive biomarkers of heart failure","volume":"21","author":"Xuan","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0154","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCRESAHA.117.310624","article-title":"Inhibition of the Cardiac fibroblast\u2013enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction","volume":"121","author":"Piccoli","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/bs.acc.2026.03.005_bib0155","doi-asserted-by":"crossref","first-page":"18446","DOI":"10.1002\/jcb.29162","article-title":"Interfering with long chain noncoding RNA ANRIL expression reduces heart failure in rats with diabetes by inhibiting myocardial oxidative stress","volume":"120","author":"Dai","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/bs.acc.2026.03.005_bib0156","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCULATIONAHA.119.042474","article-title":"Regulatory RNAs in heart failure","volume":"141","author":"Gomes","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2026.03.005_bib0157","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.12659\/MSM.904113","article-title":"Plasma long noncoding RNA urothelial carcinoma associated 1 predicts poor prognosis in chronic heart failure patients","volume":"23","author":"Yu","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/bs.acc.2026.03.005_bib0158","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cca.2014.10.023","article-title":"Multiple biomarker strategies for risk stratification in heart failure","volume":"443","author":"Bayes-Genis","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/bs.acc.2026.03.005_bib0159","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ejhf.749","article-title":"A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial","volume":"19","author":"Demissei","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0160","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/cvr\/cvab235","article-title":"Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF","volume":"118","author":"Markousis-Mavrogenis","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/bs.acc.2026.03.005_bib0161","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010156","article-title":"A peek into the future: will serial multimarker testing help bring a new era of precision medicine in heart failure patients?","volume":"16","author":"Alzate","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0162","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.579567","article-title":"The diagnostic and therapeutic value of multimarker analysis in heart failure. An approach to biomarker-targeted therapy","volume":"7","author":"Topf","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/bs.acc.2026.03.005_bib0163","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/sym17030469","article-title":"AI-driven technology in heart failure detection and diagnosis: a review of the advancement in personalized healthcare","volume":"17","author":"Udoy","year":"2025","journal-title":"Symmetry"},{"key":"10.1016\/bs.acc.2026.03.005_bib0164","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jchf.2021.01.001","article-title":"Setting the stage for a multimarker-based heart failure prevention trial?","volume":"9","author":"Ahmad","year":"2021","journal-title":"JACC Heart Fail."},{"key":"10.1016\/bs.acc.2026.03.005_bib0165","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/medicina57100996","article-title":"Could a multi-marker and machine learning approach help stratify patients with heart failure?","volume":"57","author":"Lotierzo","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/bs.acc.2026.03.005_bib0166","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10741-009-9144-z","article-title":"Multi-marker strategies in heart failure: clinical and statistical approaches","volume":"15","author":"Allen","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/bs.acc.2026.03.005_bib0167","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2011.03.006","article-title":"Multimarker approach for heart failure management: perspectives and limitations","volume":"64","author":"Giannessi","year":"2011","journal-title":"Pharmacol. Res."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242326000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242326000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:56:20Z","timestamp":1782737780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242326000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443471001"],"references-count":167,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2026.03.005","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}